Skip to main content
Erschienen in: Medical Oncology 10/2017

01.10.2017 | Short Communication

Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome

verfasst von: Anacélia Gomes de Matos, Howard Lopes Ribeiro Junior, Daniela de Paula Borges, Bruno Memória Okubo, Juliana Cordeiro de Sousa, Maritza Cavalcante Barbosa, Marilena Facundo de Castro, Romélia Pinheiro Gonçalves, Ronald Feitosa Pinheiro, Silvia Maria Meira Magalhães

Erschienen in: Medical Oncology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

The pathogenesis of myelodysplastic syndromes (MDS) is complex and depends on the interaction between aberrant hematopoietic cells and their microenvironment, probably including aberrations in cytokines and their signaling pathways. To evaluate interleukin-8 (IL-8) plasma levels and nuclear factor kappa B (NF-kB) in patients with MDS and to test possible correlation between IL-8 and NF-Kb, a total of 45 individuals were analyzed: 25 consecutive adult de novo MDS patients and 20 sex and age-matched healthy elderly volunteers. IL-8 analysis was performed by ELISA and activity of NF-kB by chemiluminescent assay. MDS patients showed higher level of IL-8 when compared to controls (p = 0.006). Patients aged 75 and above showed even higher levels (p = 0.035). NF-kB activity was significantly elevated in MDS patients when compared to controls (p < 0.0001) and higher in patients older than 75 years (p = 0.047). NF-kB activity was associated with higher serum ferritin (p = 0.042) and higher percentage of blasts (p = 0.028). A significant positive correlation between IL-8 and NF-kB was demonstrated (r = 0.480; p = 0.015). Many pathways involved in pathophysiology of MDS have been recently described, suggesting that an inflammatory process may act as a pathogenic driver. In this study, significantly elevated levels of IL-8 and NF-kB were demonstrated in MDS patients, with positive association of NF-kB with some markers of poor prognosis. A positive correlation between IL-8 and NF-kB suggests they cooperate as part of a complex networking of immune and inflammatory factors involved in MDS.
Literatur
1.
Zurück zum Zitat Gangat N, Patnaik MM, Tefferi A. Myelodysplastic syndromes: contemporary review. Am J Hematol. 2016;91:76–89.CrossRefPubMed Gangat N, Patnaik MM, Tefferi A. Myelodysplastic syndromes: contemporary review. Am J Hematol. 2016;91:76–89.CrossRefPubMed
2.
Zurück zum Zitat Magalhaes SMM, Madeira TS, Bittencourt R, Velloso E, de Lourdes Chauffaille M, Azevedo AA, et al. Epidemiological and clinicopathological data from the Brazilian registry of patients with myelodysplastic syndromes and comparative analysis between different geographic areas. Blood. 2010;116(21):1884. Magalhaes SMM, Madeira TS, Bittencourt R, Velloso E, de Lourdes Chauffaille M, Azevedo AA, et al. Epidemiological and clinicopathological data from the Brazilian registry of patients with myelodysplastic syndromes and comparative analysis between different geographic areas. Blood. 2010;116(21):1884.
3.
Zurück zum Zitat Magalhães SMM, Heredia FF, Fernandes LC, Sousa J, Almeida PJ, Souza GF, et al. Beyond race-related disparities: is myelodysplastic syndrome the same everywhere? Leuk Lymphoma. 2013;54:1564–6.CrossRefPubMed Magalhães SMM, Heredia FF, Fernandes LC, Sousa J, Almeida PJ, Souza GF, et al. Beyond race-related disparities: is myelodysplastic syndrome the same everywhere? Leuk Lymphoma. 2013;54:1564–6.CrossRefPubMed
4.
Zurück zum Zitat Belli CB, Pinheiro RF, Bestach Y, et al. Myelodysplastic syndromes in South America: a multinational study of 1080 patients. Am J Hematol. 2015;90:851–8.CrossRefPubMed Belli CB, Pinheiro RF, Bestach Y, et al. Myelodysplastic syndromes in South America: a multinational study of 1080 patients. Am J Hematol. 2015;90:851–8.CrossRefPubMed
5.
Zurück zum Zitat Gañán-Gómez I, Wei Y, Starczynowski DT, et al. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes. Leukemia. 2015;29:1458–69.CrossRefPubMedPubMedCentral Gañán-Gómez I, Wei Y, Starczynowski DT, et al. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes. Leukemia. 2015;29:1458–69.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat GlenthØj A, Ørskov AD, Hansen JW, Sine RH, O’Connell C, Grønbæk K. Immune mechanisms in myelodysplastic syndrome. Int J Mol Sci. 2016;17:944.CrossRefPubMedCentral GlenthØj A, Ørskov AD, Hansen JW, Sine RH, O’Connell C, Grønbæk K. Immune mechanisms in myelodysplastic syndrome. Int J Mol Sci. 2016;17:944.CrossRefPubMedCentral
8.
Zurück zum Zitat Wolach O, Stone R. Autoimmunity and inflammation in myelodysplastic syndromes. Acta Haematol. 2016;136:108–17.CrossRefPubMed Wolach O, Stone R. Autoimmunity and inflammation in myelodysplastic syndromes. Acta Haematol. 2016;136:108–17.CrossRefPubMed
10.
Zurück zum Zitat Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14:6735–41.CrossRefPubMed Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14:6735–41.CrossRefPubMed
11.
Zurück zum Zitat Schinke C, Giricz O, Li WL, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125:3144–52.CrossRefPubMedPubMedCentral Schinke C, Giricz O, Li WL, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125:3144–52.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kornblau SM, McCue D, Singh N, et al. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood. 2010;116:4251–61.CrossRefPubMedPubMedCentral Kornblau SM, McCue D, Singh N, et al. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood. 2010;116:4251–61.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Singh J, Simões BM, Howell SJ, et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013;15:210.CrossRefPubMedPubMedCentral Singh J, Simões BM, Howell SJ, et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013;15:210.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Zhang M, Fanf T, Wang K, et al. Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies. Onco Targets Therapy. 2016;9:3727–37.CrossRef Zhang M, Fanf T, Wang K, et al. Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies. Onco Targets Therapy. 2016;9:3727–37.CrossRef
16.
Zurück zum Zitat Braun T, Carvalho G, Coquelle A, et al. NFkB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006;107:1156–65.CrossRefPubMed Braun T, Carvalho G, Coquelle A, et al. NFkB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006;107:1156–65.CrossRefPubMed
17.
Zurück zum Zitat Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kB as the matchmaker. Nat Immunol. 2011;12(8):715–23.CrossRefPubMed Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kB as the matchmaker. Nat Immunol. 2011;12(8):715–23.CrossRefPubMed
18.
Zurück zum Zitat Gilmore TD. Introduction to NF-kB: players, pathways, perspectives. Oncogene. 2006;25:6680–4.CrossRefPubMed Gilmore TD. Introduction to NF-kB: players, pathways, perspectives. Oncogene. 2006;25:6680–4.CrossRefPubMed
19.
Zurück zum Zitat Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–65.CrossRefPubMedPubMedCentral Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–65.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51.CrossRefPubMed Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51.CrossRefPubMed
21.
Zurück zum Zitat Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed
22.
Zurück zum Zitat Flülöp T, Dupuis G, Witkowski JM, et al. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin. 2016;68:84–91. Flülöp T, Dupuis G, Witkowski JM, et al. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin. 2016;68:84–91.
23.
Zurück zum Zitat Meyers CA, Albitar M, Estey E. Cognitive impairment fatigue and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005;104:788–93.CrossRefPubMed Meyers CA, Albitar M, Estey E. Cognitive impairment fatigue and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005;104:788–93.CrossRefPubMed
24.
Zurück zum Zitat He Q, Liu F. Unexpected role of inflammatory signaling in hematopoietic stem cell development: its role beyond inflammation. Curr Opin Hematol. 2016;23:18–22.CrossRefPubMed He Q, Liu F. Unexpected role of inflammatory signaling in hematopoietic stem cell development: its role beyond inflammation. Curr Opin Hematol. 2016;23:18–22.CrossRefPubMed
25.
Zurück zum Zitat Porter JB, Garbowski M. The pathophysiology of transfusional iron overload. Hematol Oncol Clin N Am. 2014;28:683–701.CrossRef Porter JB, Garbowski M. The pathophysiology of transfusional iron overload. Hematol Oncol Clin N Am. 2014;28:683–701.CrossRef
26.
Zurück zum Zitat Banerjee A, Mifsud NA, Bird R, et al. The oral iron chelator deferasirox inhibits NF-kB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anemia. Br J Haematol. 2015;168:576–82.CrossRefPubMed Banerjee A, Mifsud NA, Bird R, et al. The oral iron chelator deferasirox inhibits NF-kB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anemia. Br J Haematol. 2015;168:576–82.CrossRefPubMed
27.
Zurück zum Zitat Yang L, Qian Y, Eksioglu E, et al. The inflammatory microenvironment in MDS. Cell Mol Life Sci. 2015;72:1959–66.CrossRefPubMed Yang L, Qian Y, Eksioglu E, et al. The inflammatory microenvironment in MDS. Cell Mol Life Sci. 2015;72:1959–66.CrossRefPubMed
Metadaten
Titel
Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome
verfasst von
Anacélia Gomes de Matos
Howard Lopes Ribeiro Junior
Daniela de Paula Borges
Bruno Memória Okubo
Juliana Cordeiro de Sousa
Maritza Cavalcante Barbosa
Marilena Facundo de Castro
Romélia Pinheiro Gonçalves
Ronald Feitosa Pinheiro
Silvia Maria Meira Magalhães
Publikationsdatum
01.10.2017
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 10/2017
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-017-1023-1

Weitere Artikel der Ausgabe 10/2017

Medical Oncology 10/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.